However, the limited number of patients with rectal cancer makes us difficult to draw a conclusion on the population of rectal cancers, and therefore, our study is limited to the population of patients with colon cancer, whether the significance of CIP2A and ATF6 applied to patients with rectal cancer need further studies. This evidence concerns the gene CIP2A and malignant colon neoplasm.